ATRO Medical

ATRO Medical

Private
NijmegenHealthcare & Life Scienceshttps://atromedical.com

Last Round

Early Funding

Feb 24, 2026

Total Funding Raised

$8.92M

Momentum Score

25 /100

Company Overview

ATRO Medical is a therapeutic devices company that develops and commercializes anatomically shaped prostheses for joint injuries, with its lead product being the Artimis® meniscus prosthesis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

meniscus prosthesisartificial meniscusmeniscus implantknee implantjoint preservationorthopedic implantknee replacement alternativeTKR alternativepost-meniscectomy painMedTechFDA Breakthrough Devicepolymer implantmedical deviceclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ATRO Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ATRO Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 24, 2026
GrantJun 8, 2022
Series ADec 14, 2021
GrantJul 16, 2020
SeedJul 17, 2017

Key People

Founding team and executive leadership

Tony van Tienen

CEO CMO

Executive Team

ATRO Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    Announced the Artimis Meniscus Prosthesis for orthopaedic care.

  • Feb 24, 2026

    $3.24M raised in early funding.

ATRO Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ATRO Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ATRO Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNijmegen
Employee Range14
Year Founded2016
Last FundingFeb 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.